In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...
Mounjaro can cause mild to moderate side effects, such as nausea, vomiting, constipation, and indigestion. According to Eli ...
Speaking about obesity and diabetes, RFK Jr. said he would rather provide people with organic food three times a day than ...
Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...
Over 35 years after the first study linking the artificial food dye Red 3 to thyroid cancer in rats was published, the U.S.
President Donald Trump’s early action on health care reversed some of his predecessor’s policies, but former President Joe ...
A new formulation for medicine that does not need cold chain support, new air cargo friendly ultra-cold storage, and the FDA ...
The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug ...
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced ...
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback